Date:
May 27, 2026
Content:
The U.S. Food and Drug Administration (FDA) has published a Form 483 directed at the Central Alabama Veterans Health Care System – West Campus in Montgomery, Alabama, following a recent facility inspection.
The Form 483 was officially issued on April 16, 2026, after FDA investigators identified specific conditions that may represent violations of federal regulatory standards. This document is part of the FDA’s routine enforcement and oversight process to ensure that healthcare and pharmaceutical facilities maintain high safety and quality protocols.
The report has been uploaded to the Office of Regulatory Affairs (OII) FOIA Electronic Reading Room for public access. This disclosure provides transparency regarding the inspection findings at the West Campus, allowing for a closer look at the operational standards currently in place at the facility.
Following the issuance of a Form 483, the facility is generally required to provide a formal response outlining corrective actions to address the observations. This oversight ensures that any potential risks to patient safety or product integrity are mitigated through rigorous compliance measures.
Source: FDA OII FOIA Electronic Reading Room
Link:
http://www.fda.gov/about-fda/fda-commissioner/central-alabama-veterans-health-care-system-west-campus-montgomery-al-483-issued-4162026
Keywords:
FDA, Form 483, Central Alabama Veterans Health Care System, Montgomery AL, VA Hospital Inspection, Compliance